Clinical Trials Directory

Trials / Unknown

UnknownNCT04470921

STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.

Detailed description

The investigators aim to optimize implementation of opportunistic salpingectomy throughout the Netherlands. The investigators will evaluate the implementation by enrolling patients in a database to evaluate healthcare experiences and to register EOC diagnosis and vital status through yearly PALGA (the nationwide network and registry of histopathology and cytopathology in the Netherlands) and municipal administration searches. In addition, the investigators will perform medical record check to assess which percentage of eligible women have been offered OS. The investigators expect that a decision aid will be a necessary tool for the decision whether women opt for an OS or not, based on their personal values. After development of the tool(s), the investigators will evaluate the implementation process.

Conditions

Interventions

TypeNameDescription
PROCEDUREOpportunistic SalpingectomyAn opportunistic salpingectomy refers to removal of the fallopian tubes without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases.

Timeline

Start date
2019-01-01
Primary completion
2025-01-01
Completion
2025-12-31
First posted
2020-07-14
Last updated
2024-01-26

Locations

27 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04470921. Inclusion in this directory is not an endorsement.